Biohaven Shares Jump 12.6% After Co's Genetic Disease Drug Meets Main Trial Goal
biohaven股價飆升12.6%,因公司遺傳疾病藥物達到主要試驗目標
Biohaven Shares Jump 12.6% After Co's Genetic Disease Drug Meets Main Trial Goal
biohaven股價飆升12.6%,因公司遺傳疾病藥物達到主要試驗目標
使用瀏覽器的分享功能,分享給你的好友吧